Renasant (RNST) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

29.01.25 00:30 Uhr

Werte in diesem Artikel
Aktien

37,40 EUR -0,40 EUR -1,06%

For the quarter ended December 2024, Renasant (RNST) reported revenue of $167.1 million, up 14.2% over the same period last year. EPS came in at $0.73, compared to $0.76 in the year-ago quarter.The reported revenue represents a surprise of +1.05% over the Zacks Consensus Estimate of $165.37 million. With the consensus EPS estimate being $0.61, the EPS surprise was +19.67%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Renasant performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Net Interest Margin: 3.4% compared to the 3.3% average estimate based on three analysts. Efficiency ratio (GAAP): 67.6% versus 66.6% estimated by three analysts on average. Total Nonperforming Loans: $113.28 million versus the two-analyst average estimate of $123.54 million. Annualized net loan charge-offs / average loans: 0.1% versus the two-analyst average estimate of 0.2%. Total Nonperforming Assets: $121.95 million compared to the $133.05 million average estimate based on two analysts. Average Balance - Total interest-earning assets: $16.07 billion versus the two-analyst average estimate of $15.90 billion. Net Interest Income: $132.88 million compared to the $130.25 million average estimate based on three analysts. Net Interest income (FTE): $135.50 million versus the three-analyst average estimate of $132.79 million. Total Noninterest Income: $34.22 million versus the three-analyst average estimate of $35.12 million. View all Key Company Metrics for Renasant here>>>Shares of Renasant have returned +4.6% over the past month versus the Zacks S&P 500 composite's +0.8% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Renasant Corporation (RNST): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Q4

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Q4

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Q4 Inc Registered Shs Unitary

Wer­bung